Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,041 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
aMAP score prediction of hepatocellular carcinoma occurrence and incidence-free rate after a sustained virologic response in chronic hepatitis C.
Yamashita Y, Joshita S, Sugiura A, Yamazaki T, Kobayashi H, Wakabayashi SI, Yamada Y, Shibata S, Kunimoto H, Iwadare T, Matsumura M, Miyabayashi C, Okumura T, Ozawa S, Nozawa Y, Kobayashi N, Komatsu M, Fujimori N, Saito H, Umemura T. Yamashita Y, et al. Among authors: kobayashi h, kobayashi n. Hepatol Res. 2021 Sep;51(9):933-942. doi: 10.1111/hepr.13689. Epub 2021 Jul 12. Hepatol Res. 2021. PMID: 34216422
Changes in liver stiffness and steatosis among patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response.
Kobayashi N, Iijima H, Tada T, Kumada T, Yoshida M, Aoki T, Nishimura T, Nakano C, Takata R, Yoh K, Ishii A, Takashima T, Sakai Y, Aizawa N, Nishikawa H, Ikeda N, Iwata Y, Enomoto H, Hirota S, Fujimoto J, Nishiguchi S. Kobayashi N, et al. Eur J Gastroenterol Hepatol. 2018 May;30(5):546-551. doi: 10.1097/MEG.0000000000001106. Eur J Gastroenterol Hepatol. 2018. PMID: 29494353
Metabolic dysfunction-associated steatotic liver disease criteria may underestimate the number of lean female nonalcoholic fatty liver disease patients with significant liver fibrosis.
Kobayashi N, Tada T, Nishimura T, Matono T, Yuri Y, Takashima T, Aizawa N, Ikeda N, Fukunishi S, Hashimoto M, Ohyanagi M, Enomoto H, Iijima H. Kobayashi N, et al. Hepatol Res. 2024 May;54(5):429-438. doi: 10.1111/hepr.13994. Epub 2023 Dec 13. Hepatol Res. 2024. PMID: 38015179
Comparison of liver stiffness assessment by transient elastography and shear wave elastography using six ultrasound devices.
Iijima H, Tada T, Kumada T, Kobayashi N, Yoshida M, Aoki T, Nishimura T, Nakano C, Ishii A, Takashima T, Sakai Y, Aizawa N, Nishikawa H, Ikeda N, Iwata Y, Enomoto H, Ide YH, Hirota S, Fujimoto J, Nishiguchi S. Iijima H, et al. Among authors: kobayashi n. Hepatol Res. 2019 Jun;49(6):676-686. doi: 10.1111/hepr.13319. Epub 2019 Mar 5. Hepatol Res. 2019. PMID: 30680865
Prevalence, clinical features, and esophagogastroduodenoscopy (EGD) findings of non-Helicobacter pylori Helicobacter infection: A study of 50 cases at a single facility in Japan.
Tsukadaira T, Hayashi S, Ota H, Kobayashi N, Sekiguchi Y, Kodaira H, Matsumoto T, Horiuchi K, Negishi T, Kurahashi M. Tsukadaira T, et al. Among authors: kobayashi n. Helicobacter. 2021 Aug;26(4):e12811. doi: 10.1111/hel.12811. Epub 2021 Apr 27. Helicobacter. 2021. PMID: 33908121
Triple-drug combination therapy versus six-month proton pump inhibitor monotherapy in non-Helicobacter pylori Helicobacter eradication, and hyperacid environment preference of Helicobacter suis: a clinical study.
Tsukadaira T, Hayashi S, Ota H, Kobayashi N, Agawa H, Kodaira H, Sekiguchi Y, Matsumoto T, Horiuchi K, Negishi T, Tada T. Tsukadaira T, et al. Among authors: kobayashi n. BMC Gastroenterol. 2024 May 8;24(1):157. doi: 10.1186/s12876-024-03252-5. BMC Gastroenterol. 2024. PMID: 38720287 Free PMC article.
5,041 results